Articles tagged with Lung Cancer
A UC Berkeley study found that children born with high levels of in utero arsenic exposure have a significantly higher risk of developing lung diseases such as bronchiectasis and lung cancer. The study, which analyzed death certificates from Chilean cities, revealed a 46 times higher death rate from bronchiectasis and seven times highe...
The American Association for Cancer Research (AACR) offers several awards and fellowships to support promising cancer scientists, including the AACR-GERTRUDE B. ELION CANCER RESEARCH AWARD, CAREER DEVELOPMENT AWARDS, and AACR-Cancer Research and Prevention Foundation Career Development Awards in Translational or Prevention Lung Cancer ...
A new screening method using cells in lung mucus can predict tumor development up to 18 months in advance. The test identified 65% of individuals who later developed symptoms of lung cancer, but also misidentified 35% of cancer-free participants.
A national analysis of local TV news health coverage reveals opportunities for improvement in accuracy and perspective. The study found that health and medical stories comprised 11% of late-evening newscasts, but often lacked specific information about disease prevalence and prevention methods.
A recent survey of 11,600 students in India found that sixth-grade students are using tobacco at a rate two to four times that of their eighth-grade peers. This trend suggests an initial wave of increased tobacco use among Indian youth, which warrants early intervention. The proportion of all deaths attributed to tobacco is expected to...
A study of 2337 lung cancer patients with advanced disease found that nearly 1% survived for five years after receiving low-dose palliative radiation therapy, including 18 who achieved an apparent cure. Prognostic factors were not found to predict survival in these patients.
Researchers found that high white blood cell counts were associated with an increased risk of cancer mortality, even after controlling for other factors. The association was strongest for lung cancer and suggested that aspirin may have a greater protective effect against cancer for those with high WBC counts.
Researchers found that bexarotene reduced tumor burden by almost 50% and inhibited malignant tumor progression by about 50% in mice. The study suggests bexarotene is a potentially viable lung cancer prevention candidate.
A study of 994 participants from north-east Belgium found a significant association between environmental cadmium exposure and an increased risk of cancer. The study, published in The Lancet Oncology, suggests that higher levels of cadmium in urine are associated with a doubling of overall cancer risk, including lung cancer.
A recent study published in Integrative Cancer Therapies found that dogs can detect breast and lung cancer with sensitivity and specificity rates of 88-97%. The trained dogs were able to identify cancers even in early stages, providing a potential reduction in uncertainty in cancer diagnosis.
A recent study suggests that individuals with a family history of lung cancer are at increased risk, with approximately a two-to-threefold higher chance of developing the illness. Researchers recommend identifying high-risk populations through data collection on family history and genetic susceptibility to facilitate targeted screening...
A study by Dana-Farber Cancer Institute found that black lung cancer patients are less likely to undergo surgery, despite equal access to care. The researchers attributed this disparity to a complex 'communications problem' underlying the interaction between doctors and patients.
A recent study published in the Journal of the National Cancer Institute found that screening chest x-rays can detect early-stage lung cancers at high rates. The study involved 77,465 participants and showed a significant reduction in lung cancer mortality among current smokers, with a detection rate of 6.3 cases per 1000 individuals.
A new study suggests a way to treat lung cancer in women, who are dying from the disease at higher rates than breast cancer. Researchers found that aromatase inhibitors can block estrogen-driven tumor growth in lung cancer cells.
A study of lung cancer patients found that those who did not participate in clinical trials were more likely to be African American, female, or over 70. The researchers suggest targeting specific patient subgroups to improve representation in clinical trials.
Researchers at the National Institute of Environmental Health Sciences discovered that the TLR4 gene plays a critical role in protecting against tumor development and chronic inflammation. This finding suggests targeting the innate immune system may be a useful tool in fighting various human diseases, including cancer.
A new study suggests that video-assisted thoracoscopic surgery can be a viable option for older patients with early-stage non-small cell lung cancer. The procedure has been shown to have low risk and good success rates, allowing patients to avoid the consequences of widespread cancer.
A new study published in Clinical Pharmacology and Therapeutics found that a nicotine vaccine was safe and well-tolerated in helping smokers quit. The vaccine, which works by producing antibodies that bind to nicotine, showed impressive results with 38% of participants quitting for at least 30 days.
Studies identify molecular markers that can predict clinical outcome for patients with non-small cell lung cancer treated with gefitinib. Researchers found subgroups of patients with specific biomarkers, including EGFR gene copy number and Akt activation status, have increased survival rates.
A new study found that increased physical activity is associated with a decreased risk of breast cancer in both black women and white women, regardless of disease stage or family history. Additionally, research on plant compound deguelin suggests it may interfere with tobacco-induced lung cancer development, while high plasma levels of...
A new variant of retinoic acid receptor beta has been discovered, which may play a role in vitamin A resistance in lung cancer. The variant, RAR-beta-1', was found to be expressed in normal lung cells and sensitive to retinoic acid, but not in resistant or lung cancer cells.
A new antibody profiling technique has been developed to identify five protein markers that can detect lung cancer with high accuracy. The technique achieved 90% sensitivity and 95% specificity in identifying cancerous versus non-cancerous patient samples.
Researchers have discovered a protein, RAR1, critical for response to retinoid treatment, which is resistant to this class of drugs. By triggering RAR1 protein expression in cancer cells, sensitivity can be restored, offering new hope for lung cancer patients.
A terminal cancer patient, D.H., has seen his cancerous tumors shrink to 10% of their original size after increasing his intake of omega-3 fatty acids. The nutritional intervention was part of a case study published in the Nutrition and Cancer journal, showing promising results for cancer treatment.
Researchers have identified compounds that can reduce cancer incidence, including thiazolidinediones for type-2 diabetes patients. Synthetic triterpenoids like CDDO-Im also show potent protection against liver tumors.
Patients with early-stage non-small cell lung cancer responded well to high doses of radiation administered through extracranial stereotactic body radiation therapy. The Phase I clinical trial treated 47 individuals with the procedure, which spared them from surgery and allowed for higher doses of radiation in a shorter period.
Researchers found that women with lung cancer have a significantly better cancer-specific, overall, and relative survival rate compared to men. In treated patients, women had a 54% lung cancer specific 5-year survival rate, while in untreated patients, women lived longer than men by 21%.
Researchers have developed a method using cheek cells to detect lung cancer with high sensitivity and specificity. The test uses Automated Quantitative Cytometry (AQC) to analyze buccal cell nuclei and predict the likelihood of cancer presence.
A recent study published in The Lancet found that consuming cruciferous vegetables may protect against lung cancer, particularly for individuals with inactive forms of specific genes. The research revealed a 33% protective effect in those with an inactive GSTM1 gene and a 37% effect in those with an inactive GSTT1 gene.
The Lance Armstrong Foundation has established an endowed chair in oncology at Indiana University, providing $1.5 million for research and program development. Dr. Einhorn, a renowned expert on urologic cancer, will lead the initiative to improve patient therapies and quality of life.
New therapy Iressa shows no significant survival improvement for NSCLC patients, but offers better outcomes for Asian and non-smoking patients. The study results provide insight into the effectiveness of EGFR inhibitors in specific patient groups.
Researchers at Ohio State University discovered that restoring the missing or silenced WWOX gene can slow or stop lung-cancer cell growth. The study showed that reactivating the gene is highly effective in stopping human lung tumor growth in mice, suggesting a potential therapeutic approach for lung cancer treatment.
Researchers found that gene therapy using manganese superoxide dismutase plasmid liposome (MnSOD-PL) protected healthy tissue from damage during and after radiation retreatment. The therapy significantly improved survival rates and reduced side effects in lung cancer patients.
A recent study found that African-American women with faulty cell cycle checkpoints are at a nearly five-fold increased risk of developing lung cancer. The study suggests that less effective cell cycle checkpoints may lead to genetic instability and increased cancer risk in this population.
The annual report shows cancer death rates decreasing for 12 of the top 15 cancers in men and nine in women, with lung cancer remaining a leading cause. Overall incidence rates have been stable since 1992, but breast cancer incidence has increased due to rising rates for six other cancers.
A large US population study found that eating foods with phytoestrogens, such as soy and fruits, may lower lung cancer risk. The study, involving over 3,500 participants, discovered a 46% reduced risk of developing lung cancer among those who consumed the highest amount of phytoestrogen-rich foods.
A population-based study with up to 31 years of follow-up found that reducing tobacco consumption from heavy smoking can lower lung cancer risk. Heavy smokers who cut their daily intake by half saw a 27% reduction in lung cancer risk compared to unchanged heavy smokers.
A study found that increased intake of phytoestrogens, found in soy products and certain fruits and vegetables, was associated with a lower risk of lung cancer. The study analyzed data from over 1,600 patients with lung cancer and matched healthy controls, revealing sex-specific differences in protective effects.
A study tracking 43,000 men and women found that light smoking (1-4 cigarettes/day) significantly increases the risk of coronary artery disease and lung cancer. Women are almost five times as likely to die from lung cancer compared to non-smokers.
A study of nearly 60,000 French women found that beta-carotene intake was inversely associated with tobacco-related cancer risk in never-smokers, but increased the risk in former and current smokers. The researchers also calculated that the absolute rates of tobacco-related cancers over 10 years varied significantly between nonsmoking ...
A Phase II study found erlotinib to be relatively well-tolerated and demonstrated encouraging activity in previously untreated patients 70 years or older with advanced lung cancer. The study showed a median survival of 46 weeks, with 60% of patients experiencing partial response or stable disease.
Researchers discovered that compounds from cruciferous veggies can slow down benign to malignant tumors in mice, suggesting potential protection against lung cancer development. The studies also found that these compounds can push human lung cells to commit 'suicide', stopping fast-growing cancer cells.
Researchers at Thomas Jefferson University found that giving chemotherapy and radiation together from the start may help patients with locally advanced lung cancer live longer. The study compared three treatment approaches and showed that combining chemotherapy and radiation improved patient outcomes.
Researchers at UT Southwestern Medical Center found a compound called GRN163L that blocks the enzyme telomerase, which keeps cells immortal and implicated in most human cancers. The compound works rapidly and in doses considered reasonable for therapy.
Research finds that neutropenia, a type of hematological toxicity, is associated with increased overall survival in patients with advanced non-small cell lung cancer. Prospective trials are needed to assess whether drug dosing guided by toxic effects could improve chemotherapy efficacy.
Researchers explore specific tobacco cancer biochemistry and epidemiology, shedding light on why some smokers develop lung cancer while others do not. Key findings include the role of polycyclic aromatic hydrocarbons in forming lesions that lead to gene mutations.
A study published in JAMA Network found that a diagnostic strategy combining Transesophageal ultrasound-guided fine needle aspiration (EUS-FNA) and mediastinoscopy can identify more patients with tumor invasion or lymph node metastases, reducing unnecessary thoracotomies by 16%.
Researchers found that gefitinib (Iressa) was significantly effective in treating lung cancer cells containing a mutant EGFR molecule, while cetuximab (Erbitux) had little effect. The study suggests that mutations in the targets of designer drugs critically influence their effectiveness.
Researchers found that gefitinib was more effective at inhibiting cell growth and increasing apoptosis in NSCLC cells with mutant EGFR. In contrast, cetuximab showed no significant response in patients with EGFR mutations.
Scientists at Ohio State University created a mouse model of lung cancer that loses the FHIT gene's protein early in development, leading to larger and more numerous tumors. The study suggests that even low levels of the protein might prevent lung cancer.
Researchers design dual-chamber nanocell to deliver anti-angiogenic and chemotherapy drugs to tumors, reducing toxicity and improving survival rates. The new approach shows great potential in treating two types of cancers, with mice surviving up to 65 days without severe side effects.
Researchers found that PGE2 up-regulates T-regulatory cells, suppressing immune function and fueling cancer growth. The study suggests using COX-2 inhibitors like Celebrex to augment immune responses in cancer patients.
A trial involving 731 patients found that treatment with erlotinib resulted in longer survival compared to a placebo, with patients on erlotinib surviving an average of 6.7 months versus 4.7 months. Erlotinib was also well-tolerated and improved physical function, quality of life, and symptoms.
A new report by the European Society for Medical Oncology reveals that female lung cancer death rates in Europe are still rising, despite a 16% increase between 1990-2001. However, trends in some countries and among younger women show a decline, suggesting future hope for reducing this epidemic.
Researchers at Dana-Farber Cancer Institute have identified regions of irregular gene copy numbers in non-small cell lung cancer cells, pointing to a large number of previously unknown cancer-causing genes. The study also found that certain genes, including p63, play a role in the development of squamous cell carcinomas.
Christine Chung, a Vanderbilt researcher, has won the Damon Runyon Research Foundation/Lilly Clinical Investigator Award to support her work on genetic profiling for head and neck cancers. The award will provide funding for DNA microarray technology to predict tumor recurrence and response to chemotherapies.
A new study finds that post-surgical chemotherapy significantly improves five-year survival rates for patients with non-small cell lung cancer, reducing cancer recurrence by 49% compared to surgery alone. The treatment is inexpensive and has limited side effects, paving the way for a new standard of care.
A study found that relatives of black patients with early-onset lung cancer had a risk of developing lung cancer that was more than twice as high as those of white patients. Smokers with a family history of early-onset lung cancer also faced an increased risk, especially after age 60.
Researchers at UNC Chapel Hill found that radiation exposure at older ages significantly increases the risk of lung cancer among Hanford nuclear workers. The study analyzed data from 26,389 workers hired between 1944 and 1978 and identified 2,265 cancer deaths.
Researchers at NIST have developed a new DNA sequencing chip that detects mtDNA changes associated with early cancer. The chip promises faster, easier interpretation, and higher throughput than current methods, potentially revolutionizing early clinical cancer diagnosis.